99$/KG
89$/KG
Product Detailed Description
Liposomal Proanthocyanidins 70% is a premium-grade dietary supplement ingredient delivering proanthocyanidins in an advanced liposomal delivery system. Proanthocyanidins (CAS 4852-22-6), also known as procyanidins, oligomeric proanthocyanidins (OPCs), or procyanidolic oligomers (PCOs), are a class of polyphenolic bioflavonoids characterized by the molecular formula C₃₀H₂₆O₁₃ and a molecular weight of 594.52 g/mol. They are composed of oligomers and polymers of flavan-3-ol units, primarily catechin and epicatechin, linked through carbon-carbon bonds. Proanthocyanidins occur as reddish-brown to reddish-brown fine powder with a slight characteristic odor and astringent taste.
Proanthocyanidins are widely distributed in the plant kingdom, with the most commercially significant sources being grape seed extract (Vitis vinifera) and maritime pine bark extract (Pinus pinaster). Grape seed proanthocyanidin extract (GSPE) constituents are based on either catechin or epicatechin, and include monomers, dimers, trimers, and other oligomers, with dimeric procyanidins designated as procyanidin B1, B2, B3, and B4 depending on the configuration of catechin and epicatechin subunits. Proanthocyanidins are widely used for the treatment of vascular disorders such as varicose veins, venous insufficiency, and microvascular problems in Europe.
Conventional oral proanthocyanidins present significant bioavailability challenges. Proanthocyanidins display lower stability and are susceptible to degradation during storage and gastrointestinal transit. Their high molecular weight and polymeric nature limit their biological activity due to poor bioavailability, and the poor biostability and bioavailability of proanthocyanidins significantly limit their therapeutic applications.
Liposomal encapsulation provides four critical advantages:
1. Dramatically Enhanced Bioaccessibility — Ultrasonic-assisted nanoencapsulation of proanthocyanidins in liposomes using lecithin-based nanoliposomes achieved an encapsulation efficiency of 73.84% and increased bioaccessibility during in vitro digestion by 2.28–3.07-fold, with in vivo analyses showing over 200% increase in bioaccessibility compared to the control. This nanoliposomal delivery system effectively overcomes the bioavailability and stability limitations of free proanthocyanidins, providing new insights into the management of oxidative stress in inflammatory diseases.
2. High Encapsulation Efficiency and Stability — Liposomal and chitosan-coated liposomal nanocarriers for grape seed proanthocyanidins displayed high encapsulation efficiency exceeding 90% with particle sizes of 120–150 nm and low polydispersity. Co-encapsulation of proanthocyanidins with α-tocopherol in complex phospholipid liposomes achieved encapsulation efficiencies of 78.02% ± 2.02% and 81.67% ± 1.25%, respectively, with retention remaining above 60% after 30 days of storage at 4°C.
3. Synergistic Antioxidant Enhancement — Co-encapsulation of proanthocyanidins with α-tocopherol in complex phospholipid liposomes resulted in a synergistic antioxidant effect, with DPPH radical scavenging activity reaching 87.52%, significantly higher than that of single-embedded proanthocyanidin and α-tocopherol liposomes.
4. Sustained Release and Targeted Delivery — The release of proanthocyanidins from liposomal formulations during simulated digestion was low and followed the Ritger-Peppas release model, indicating a remarkable sustained release and delivery to the small intestine. Liposomal encapsulation protects proanthocyanidins from degradation during gastric transit and facilitates targeted delivery to the intestinal epithelium where absorption occurs.
| Field | Details |
|---|---|
| Product Name | Liposomal Proanthocyanidins 70% |
| CAS No. | 4852-22-6 |
| Active Ingredient | Proanthocyanidins (Oligomeric Proanthocyanidins, OPCs) |
| Molecular Formula | C₃₀H₂₆O₁₃ |
| Molecular Weight | 594.52 g/mol |
| Assay Method | HPLC with gel permeation chromatography (non-aqueous elution system) for oligomeric proanthocyanidin quantification (USP method); UV spectrophotometry at 500 nm for total proanthocyanidin content; normal-phase HPLC for extractable proanthocyanidins with different degrees of polymerization; reversed-phase HPLC after thioacidolysis for unextractable proanthocyanidins |
| Purity | ≥ 70% oligomeric proanthocyanidins (OPC) by HPLC; ≥ 95% total proanthocyanidins by UV |
| Appearance / Color | Reddish-brown to reddish-brown fine powder |
| Odor | Slight characteristic odor |
| Taste | Slightly astringent |
| Solubility | Dispersible in water, forming a stable liposomal suspension; do not dissolve in alcohol or strong surfactants, which disrupt the liposomes |
| Particle Size | 100% through 80 mesh (native powder); 120–150 nm (reconstituted liposomes) |
| Dosage Form | Liposomal powder, water-dispersible |
| Recommended Dosage | 100–400 mg per day; clinical trials have used 250 mg/day (NAFLD), 300 mg/day (T2DM with UTI), and 320 mg/day (mild cognitive impairment) |
| Application | Antioxidant defense, cardiovascular health (venous insufficiency, capillary fragility), cognitive function, metabolic health, anti-inflammatory support, cellular longevity, skin health |
| Extract Source | Grape seed (Vitis vinifera) extract or maritime pine bark (Pinus pinaster) extract; sunflower phospholipid liposomal carrier system |
| Loss on Drying | ≤ 5.0% |
| Heavy Metals | ≤ 10 ppm |
| Residual Solvents | < 10 ppm |
| Lead Time | In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks |
| Shipping Method | International Express (FedEx / DHL / UPS); air and sea freight available; worldwide shipping including remote areas. Shipped in tightly sealed, light-protective containers under cool, dry conditions |
| Storage | Store sealed in a cool, dry place, protected from light, heat, and moisture. Keep container tightly closed. Shelf life: 24 months |
| Packaging | 1 kg/aluminum foil bag with two plastic bags inside; 25 kg/carton or fiber drum with aluminum foil bag inside |
High Purity — Standardized to ≥70% oligomeric proanthocyanidins by HPLC and ≥95% total proanthocyanidins by UV, ensuring consistent active content.
Liposomal Enhancement — Ultrasonic-assisted nanoencapsulation achieves 73.84% encapsulation efficiency and increases bioaccessibility by 2.28–3.07-fold (in vitro) and over 200% (in vivo) compared to free proanthocyanidins.
Potent Antioxidant Activity — Proanthocyanidins are among the most effective free radical scavengers ever discovered, with antioxidant activity significantly higher than vitamins C and E, and GSPE causes a 60–90% reduction in oxidation of LDL-C.
Cardiovascular Health Support — Proanthocyanidins help maintain capillary integrity, support healthy venous function, and reduce LDL oxidation, supporting cardiovascular health.
Clinically Studied for NAFLD — A randomized controlled trial in 50 patients with non-alcoholic fatty liver disease used 500 mg/day of GSE containing 250 mg of proanthocyanidins for two months.
Clinically Studied for Cognitive Function — A randomized, double-blind, placebo-controlled clinical trial evaluated GSPE at 320 mg/day on cognitive function in older adults with mild cognitive impairment (MCI).
Synergistic Formulation Potential — Co-encapsulation with α-tocopherol in complex phospholipid liposomes significantly enhances antioxidant activity through synergistic effects, with DPPH radical scavenging activity reaching 87.52%.
Water-Dispersible — Liposomal powder offers excellent dispersibility in aqueous systems; suitable for capsules, tablets, powder drink mixes, and functional beverages.
Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.
| Application | Recommended Usage | Notes |
|---|---|---|
| Capsules / Tablets | 100–250 mg per serving | 1–2 capsules daily with meals |
| Functional Beverages | 50–125 mg per 250 mL | Water-dispersible; suitable for RTD formats |
| Powdered Drink Mixes | 100–320 mg per sachet | Best absorbed when taken with food |
| Cardiovascular Formulas | 150–250 mg per serving | Often combined with vitamin C, CoQ10, or omega-3 fatty acids |
| Cognitive Support Formulas | 200–320 mg per serving | Clinical trial used 320 mg/day for MCI |
| Metabolic Health Formulas | 250 mg per serving | Clinical trial used 250 mg/day for NAFLD |
Clinical studies have evaluated proanthocyanidins across a range of doses. A randomized controlled trial in 50 patients with non-alcoholic fatty liver disease used 2 tablets of grape seed extract containing 250 mg of proanthocyanidins per tablet for two months. A randomized, double-blind, placebo-controlled clinical trial evaluated grape seed proanthocyanidin extract (GSPE) at 320 mg per day on cognitive function in older adults with mild cognitive impairment (MCI). A study in patients with type 2 diabetes and urinary tract infections used GSPE at 300 mg once daily in combination with metformin for 12 weeks. Cranberry proanthocyanidins have been studied at doses of 2 × 18.5 mg daily (37 mg/day) for urinary tract infection prevention in healthy women. For general antioxidant and cardiovascular support, 100–250 mg daily is commonly used. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability and protection from degradation.
Important Safety Information: Proanthocyanidins are generally well tolerated. The most common side effects are mild gastrointestinal discomfort, including nausea, abdominal cramping, and diarrhea, particularly at high doses. Individuals with known hypersensitivity to proanthocyanidins or related polyphenols should avoid supplementation. Proanthocyanidins may interact with certain medications, including anticoagulants and antiplatelet agents. Pregnant or lactating women and children should consult a healthcare professional before use.
Stock Orders: 3–5 business days after payment confirmation.
Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.
Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.
Coverage: Worldwide shipping, including remote areas.
proanthocyanidins Encyclopedia — Scientific Background
Proanthocyanidins (CAS 4852-22-6), also known as procyanidins, oligomeric proanthocyanidins (OPCs), or condensed tannins, are a class of polyphenolic bioflavonoids characterized by the molecular formula C₃₀H₂₆O₁₃ and a molecular weight of 594.52 g/mol. They are composed of oligomers and polymers of flavan-3-ol units, primarily catechin and epicatechin, linked through carbon-carbon bonds. Proanthocyanidins are one of the most beneficial groups of plant flavonoids, and the most active proanthocyanidins are those bound to other proanthocyanidins.
| Property | Value |
|---|---|
| CAS No. | 4852-22-6 |
| Molecular Formula | C₃₀H₂₆O₁₃ |
| Molecular Weight | 594.52 g/mol |
| Synonyms | Procyanidins, Oligomeric Proanthocyanidins (OPCs), Procyanidolic Oligomers (PCOs), Condensed Tannins |
| Appearance | Reddish-brown to reddish-brown fine powder |
| Odor | Slight characteristic odor |
| Taste | Slightly astringent |
| Solubility | Soluble in water and most organic solvents; astringent taste |
The most biologically active proanthocyanidins are the oligomeric forms—dimers, trimers, and tetramers—collectively referred to as oligomeric proanthocyanidins (OPCs) or procyanidolic oligomers (PCOs). These lower molecular weight oligomers are more readily absorbed and demonstrate superior bioavailability compared to high molecular weight polymeric proanthocyanidins. The high molecular weight of polymeric proanthocyanidins limits their biological activity due to poor bioavailability.
Commercial OPC sources include extracts from grape seed skin (Vitis vinifera) and the bark of the maritime (Landes) pine, which are used interchangeably because of their similar chemical composition and pharmacological profiles.
Proanthocyanidins are critical for several physiological functions:
Antioxidant Defense — Proanthocyanidins are powerful antioxidants with activity significantly higher than vitamins C and E, and they help release catechin, which synergizes with ascorbic acid to suppress free radicals.
Cardiovascular Health — Grape seed proanthocyanidin extract (GSPE) causes a 60–90% reduction in oxidation of LDL-C, consequently reducing atherosclerosis. GSPE is widely used for treatment of vascular disorders such as varicose veins, venous insufficiency, and microvascular problems.
Cognitive Function — Clinical trials have evaluated GSPE for its effects on cognitive function in older adults with mild cognitive impairment.
Metabolic Health — Proanthocyanidins have been studied for their effects in non-alcoholic fatty liver disease and type 2 diabetes.
Anti-Inflammatory Activity — Proanthocyanidins play a crucial role in inflammatory conditions through their antioxidant and anti-inflammatory properties, effectively regulating oxidative stress and inflammatory responses.
Proanthocyanidins are among the most effective free radical scavengers ever discovered, with antioxidant activity higher than vitamins C and E. Their structure contains multiple phenolic hydroxyl groups that enable efficient scavenging of reactive oxygen species (ROS) and reactive nitrogen species (RNS). GSPE causes a 60–90% reduction in oxidation of LDL-C, a key early step in atherosclerosis.
Liposomal encapsulation of proanthocyanidins provides a fundamentally different delivery mechanism from conventional forms. Ultrasonic-assisted nanoencapsulation using lecithin-based nanoliposomes significantly improved physicochemical stability, homogeneity, and encapsulation efficiency (73.84%) relative to control. The PKLPs bioaccessibility during in vitro digestion increased by 2.28–3.07-fold, with a remarkable sustained release and delivery to the small intestine. In vivo analyses showed over 200% increase in bioaccessibility compared to the control.
Co-encapsulation of proanthocyanidins with α-tocopherol in complex phospholipid liposomes resulted in a synergistic antioxidant effect. The DPPH radical scavenging activity of the co-encapsulated formulation reached 87.52%, significantly higher than that of single-embedded proanthocyanidin and α-tocopherol liposomes. The encapsulation efficiency of proanthocyanidins and α-tocopherol reached 78.02% ± 2.02% and 81.67% ± 1.25%, respectively, and interacted with the phospholipid bilayer through hydrogen bonding.
Despite their potent antioxidant activity, native proanthocyanidins present significant bioavailability challenges. Proanthocyanidins display lower stability and are susceptible to degradation during storage and gastrointestinal transit. Their high molecular weight and polymeric nature limit their biological activity due to poor bioavailability. The poor biostability and bioavailability of proanthocyanidins significantly limit their therapeutic applications.
These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Ultrasonic-assisted nanoencapsulation of proanthocyanidins in liposomes effectively overcomes the bioavailability and stability limitations of free proanthocyanidins, providing new insights into the management of oxidative stress in inflammatory diseases.
Liposomal encapsulation of proanthocyanidins provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the proanthocyanidin molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:
Achieves 73.84% encapsulation efficiency with ultrasonic-assisted nanoencapsulation
Increases bioaccessibility by 2.28–3.07-fold (in vitro) and over 200% (in vivo) compared to free proanthocyanidins
Achieves encapsulation efficiency exceeding 90% with chitosan-coated liposomal nanocarriers
Provides synergistic antioxidant enhancement when co-encapsulated with α-tocopherol
Enables sustained release and targeted delivery to the small intestine
A randomized clinical trial assigned 50 patients with NAFLD to receive either 2 tablets of grape seed extract containing 250 mg of proanthocyanidins or placebo for two months. The study evaluated the effects of GSE supplementation on liver health parameters.
A randomized, double-blind, placebo-controlled clinical trial evaluated the effects of GSPE at a dosage of 320 mg per day on cognitive function in older adults with mild cognitive impairment (MCI).
A clinical trial in 60 adults with type 2 diabetes and urinary tract infections randomly assigned participants to receive metformin alone (control) or a combination of GSPE (300 mg once daily) and metformin for 12 weeks.
A randomized controlled trial evaluated cranberry proanthocyanidins for the prevention of recurrent urinary tract infection in healthy women. Participants received a high dose of standardized cranberry proanthocyanidins (2 × 18.5 mg daily) or a control low dose (2 × 1 mg daily) for a 24-week period.
Proanthocyanidins have a well-established safety profile. They are widely consumed as dietary supplements and are present in numerous foods including red wine, grape juice, and dark chocolate. The most common side effects are mild gastrointestinal discomfort, including nausea, abdominal cramping, and diarrhea, particularly at high doses.
Regulatory Status:
United States — Proanthocyanidins are regulated as dietary supplement ingredients. Grape seed extract and pine bark extract are generally recognized as safe (GRAS) for use in food and dietary supplements.
European Union — Proanthocyanidins are authorized as food supplement ingredients in EU member states. Grape seed extract is used as an active ingredient of medicinal products for the treatment of circulatory disorders such as capillary fragility.
Global Standards — Proanthocyanidins are monographed in the USP with HPLC methods for quantification. The USP has established a gel permeation chromatography method with non-aqueous elution for the determination of oligomeric proanthocyanidins.
Precautions: Proanthocyanidins are generally well tolerated. Individuals with known hypersensitivity to proanthocyanidins or related polyphenols should avoid supplementation. Proanthocyanidins may interact with certain medications, including anticoagulants and antiplatelet agents. Pregnant or lactating women and children should consult a healthcare professional before use.
Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.
This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.
99$/KG
89$/KG
RELATED
RELATED
RELATED
RELATED
This website uses cookies to ensure you get the best experience on our website.
Comment
(0)